Portfolio Manager Mikael Petersson comments Amgen’s acquisition of Nuevolution

“Amgen, the world’s largest biotech company with $100 billion in market cap, bidding for Nuevolution shows that our holding owns a very unique asset,” Mikael Petersson comments on the announcement that Amagen acquire Copenhagen-based biopharmaceutical company Nuevolution.

Read the article here

Subscribe to the latest news